It’s Time We Put an End to Alzheimer’s Disease

With your help, Truebinding can make that possible

The recruitment for this potentially revolutionary Alzheimer's treatment study was closed

  • Safety is our highest priority

    At Truebinding we make sure every precaution is taken to ensure the safety of you and your loved ones. To date no participants have had any adverse reactions or side effects.

  • A New Effective Treatment

    We believe that everyone has the right to live a full and happy life unburdened by mental illness, and it’s why we’re working so hard to develop an effective treatment, and with your help, we can. Data from our pre-clinical AD studies have shown to even have an increase in Neurogenesis (new brain cell growth).

  • We Make Participation Easy

    Being a caregiver is hard, we at Truebinding recognize that. It’s why we take every avenue possible to cater to you and your loved ones. Most clinical trials studying Alzheimer’s last anywhere from 2 to 6 years. Truebinding’s clinical trial is only for one month. On top of that we also offer options for the Caregivers to take the break they deserve.

 

Years of Research and Development have Brought us To this Moment

 

Dare to Dream

At Truebinding, we dream of a day when neurodegenerative disorders like Alzheimer’s disease are a thing of the past. It’s why we work tirelessly to see this dream come true. After years of research and development we’ve created TB006, and the effects it has could be revolutionary.

Find a Location

It’s time to stamp out Alzheimer’s Disease

We have big hopes for TB006, but we need your help. There are minimal requirements to participate in our clinical trials and participation only lasts for a month. The time to end this terrible disease is now.

Find a Location
 

 FAQs

 

  • Currently our clinical trial has no age limit for participants.

  • Our trial is only one month, so you can decide whether they want to continue treatment based on the result. Other trials usually last much longer, some are even 2-6 years. We believe our trial will show efficacy in a month.

  • Yes, we are currently implementing an Open-Label Extension for those who see benefits and wish to extend the time they are receiving treatments.

  • We like to think of it like this. Your body is like a car. When you use it a lot and never change the engine oil, it's going to cause all kinds of problems to the body. So TB006 is used to dissolve the build up in your body and cycle it out. So we can see the body condition get improved.

  • MMSE score lower than 24 is eligible. For other companies, a lot of trials only target very early stage patients with MMSE scores higher than 24, but we at Truebinding want to make sure we include everyone we can which is why we set the limit at 24.

  • Hypertension and diabetes are inclusive within our clinical trial.

  • While most trials exclude patients with cerebrovascular diseases, at Truebinding we do our best to make sure they are included. As long as the dementia is not caused by cerebrovascular disease they should be included.

Have a question not covered above? Fill out the form below to get in touch with one of our knowledgeable representatives.

Get in touch.

If you have any questions, or you’re ready to sign up, fill out the form below and one of our clinical site support specialists will contact you. Help us free the world from Alzheimer’s, and together we’ll create a better, longer life for everyone.